These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16442639)

  • 21. Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration.
    Kinyanjui MW; Ramos-Barbón D; Villeneuve A; Fixman ED
    J Immunol Methods; 2006 Jul; 314(1-2):80-9. PubMed ID: 16842814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.
    Simmons A; Whitehead RP; Kolokoltsov AA; Davey RA
    Virol J; 2006 Feb; 3():8. PubMed ID: 16507098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
    Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA transposons for modification of human primary T lymphocytes.
    Huang X; Wilber A; McIvor RS; Zhou X
    Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
    Griffioen M; van Egmond HM; Barnby-Porritt H; van der Hoorn MA; Hagedoorn RS; Kester MG; Schwabe N; Willemze R; Falkenburg JH; Heemskerk MH
    Haematologica; 2008 Oct; 93(10):1535-43. PubMed ID: 18768532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an immortalized human CD4+ T cell clone inhibiting tumor growth in mice.
    Pecher G; Harnack U; Günther M; Hummel M; Fichtner I; Schenk JA
    Biochem Biophys Res Commun; 2001 May; 283(4):738-42. PubMed ID: 11350045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific and non-specific helper activities derived from supernatants of human influenza virus-specific T-cell lines.
    Zanders ED; Fischer A; Smith S; Beverley PC; Feldmann M
    Immunology; 1983 Feb; 48(2):361-6. PubMed ID: 6401688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human gammadelta T cells modulate the mite allergen-specific T-helper type 2-skewed immunity.
    Korematsu S; Tanaka Y; Nagakura T; Minato N; Izumi T
    Clin Exp Allergy; 2007 Nov; 37(11):1681-7. PubMed ID: 17883427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
    Strauss G; Osen W; Knape I; Jacobsen EM; Müller SM; Debatin KM
    Cell Death Differ; 2007 Mar; 14(3):480-8. PubMed ID: 16902496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
    Paine A; Oelke M; Blasczyk R; Eiz-Vesper B
    Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of T-cell lines.
    Kahlert H
    Methods Mol Med; 2008; 138():31-41. PubMed ID: 18612602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects.
    Mustafa AS
    Med Princ Pract; 2009; 18(5):385-92. PubMed ID: 19648762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK; Lane TA; Ball ED
    Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.